PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$20.02
0.00 (0.00%)
▲
5d:
-6.97%
30d:
-15.71%
90d:
-17.03%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.18
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$23.08
13.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $20.02, which is considered oversold relative to its 30-day fair value range of $20.87 to $23.49. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.7) compared to its historical average (21.2). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This pessimistic expectation contrasts with the company's recent 132.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRVA is in a downtrend. The price is currently testing key support at $19.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.95 (+59.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRVA is in a downtrend. The price is currently testing key support at $19.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $31.95 (+59.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$20.87 -
$23.49
Company Quality Score
54/100
(HOLD)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.6% below Wall St target ($31.95)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$20.87 -
$23.49
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.53
(7.6%)
Support & Resistance Levels
Support Level
$19.53
Resistance Level
$22.50
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.67
Wall Street Target
$31.95
(+59.6%)
Revenue Growth (YoY)
17.4%
Earnings Growth (YoY)
132.8%
Profit Margin
1.1%
Valuation Discount vs History
-7.7% cheaper
PE vs Historical
16.7 vs 21.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.7%
(market-implied from PE analysis)
1-Year Target
$18.48
(-8%)
2-Year Target
$17.06
(-15%)
3-Year Target
$15.74
(-21%)
3-Yr Target (if PE normalizes)
(PE: 17→21)
$20.02
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.8%)
$37.49
(+87%)
Base:
(SPY PE: 16.7, Growth: 11.8%)
$27.96
(+40%)
Bear:
(PE: 14.2, Growth: 11.8%)
$23.77
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 19.12 | Forward EPS (Implied): $1.13
Bull Case
$25.99
(+21%)
Analyst growth 15.0%, PE expands to 20.1
Base Case
$21.52
(0%)
Market implied 0.0%, PE stable at 19.1
Bear Case
$16.46
(-24%)
Severe decline -15.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.7 to 21.2
Stabilization Target:
$25.46
(+27.2%)
PE Expansion Potential:
+27.2%
Share & Embed Analysis
Last updated: March 31, 2026 5:23 AM ET
Data refreshes hourly during market hours. Next update: 6:23 AM
Data refreshes hourly during market hours. Next update: 6:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Parth Mehrotra
SELL
26509 shares
2026-03-16
David Mountcastle
SELL
6391 shares
2026-03-16
David Mountcastle
SELL
6565 shares
2026-03-13
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 61 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$37 | 56 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
